BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  FoRx Therapeutics AG Raises EUR 10 Million Seed Round

  FoRx Therapeutics AG, the biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways, announced the closing of a EUR 10 million seed financing led by M Ventures, Novartis Venture Fund and Omega Funds.

  April 26, 2020

   · 

  5 min read
• Lonza to Host New Webinar – “3D Cell Culture Models for Respiratory Research”

  Free Lonza webinar to discuss the benefits of using physiologically relevant 3D cell culture models to enhance respiratory research for diseases like COVID-19

  April 26, 2020

   · 

  3 min read
• Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)

  HMM0112 is a Phase I trial conducted in the United States in Type 2 Diabetes (T2D) patients with insufficiently controlled blood glucose levels while on metformin, DPP-4 inhibitors or SGLT-2 inhibitors, alone or in combination treatment.

  April 26, 2020

   · 

  4 min read
• Policy

  Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme’s ENHANZE® Technology For Patients With Multiple Myeloma

  Halozyme Therapeutics, Inc. announced the submission of a New Drug Application to the Ministry of Health, Labour and Welfare by Janssen Pharmaceutical K.K. seeking approval of a new subcutaneous formulation of daratumumab, an intravenous treatment approved for patients with multiple myeloma.

  April 26, 2020

   · 

  4 min read